REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - MEDTRONIC INC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 9223UFIL Limited21 October 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
20-October-2014
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
31,058,092 3.16
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
2,500 0.00
Total
31,058,092 3.16
2,500 0.00
Please note that the above positions include cancelled purchases for 56 shares from 16 Oct 2014.
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(63) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
8,978
63.0000 USD/ Share
Buy
7,600
63.3430 USD/ Share
Buy
472
63.3750 USD/ Share
Buy
16,666
63.3429 USD/ Share
Buy
4,400
63.3341 USD/ Share
Buy
12,667
63.3507 USD/ Share
Buy
12,817
63.3410 USD/ Share
Buy
1,300
63.2592 USD/ Share
Buy
25,000
63.5400 USD/ Share
Buy
50,000
63.7450 USD/ Share
Buy
16,000
63.8690 USD/ Share
Buy
5,900
63.8450 USD/ Share
Buy
9,400
63.8854 USD/ Share
Buy
3,500
63.8822 USD/ Share
Buy
10,500
63.8799 USD/ Share
Buy
1,100
63.8800 USD/ Share
Buy
500
63.8850 USD/ Share
Buy
45,600
63.6494 USD/ Share
Sale
5,900
63.8450 USD/ Share
Sale
2,303
63.5418 USD/ Share
Sale
16,000
63.8690 USD/ Share
Buy
9,800
62.2900 USD/ Share
Buy
15,900
62.7187 USD/ Share
Sale
3,800
62.2900 USD/ Share
Sale
5
63.8400 USD/ Share
Buy
80
62.42 USD/ Share
Buy
42
61.69 USD/ Share
Buy
12
62.49 USD/ Share
Buy
72
61.53 USD/ Share
Buy
12
61.75 USD/ Share
Buy
18
62.48 USD/ Share
Buy
1
61.68 USD/ Share
Buy
2
61.52 USD/ Share
Sale
40
62.37 USD/ Share
Sale
211
61.56 USD/ Share
Sale
6
62.48 USD/ Share
Sale
6
61.76 USD/ Share
Sale
35
61.68 USD/ Share
Sale
20
61.91 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Date of disclosure
21 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEZFLFLZBFZFBE
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement